AI assistant
Sending…
VYNE Therapeutics Inc. — Director's Dealing 2021
Apr 2, 2021
35290_dirs_2021-04-02_1e1f50ef-34db-4926-bc9f-71e8eac98ede.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VYNE Therapeutics Inc. (VYNE)
CIK: 0001566044
Period of Report: 2021-03-31
Reporting Person: Harsch Mutya (Chief Legal Officer and GC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | Common Stock | F | 1765 | $6.84 | Disposed | 108873 | Direct |
Footnotes
F1: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.